Nishida et al. treated renal cancer cells with BET inhibitor JQ1 to reduce DRD4 binding and CXC chemokine transcription, thereby inhibiting renal cancer metastasis and neutrophil infiltration [99]. This evidence concerns the gene DRD4 and renal carcinoma.